Found: 152
Select item for more details and to access through your institution.
Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 11, p. 2351, doi. 10.1007/s00432-017-2482-7
- By:
- Publication type:
- Article
Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 8, p. 1383, doi. 10.1007/s00432-013-1452-y
- By:
- Publication type:
- Article
Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy.
- Published in:
- Journal of Gastroenterology, 2007, v. 42, n. 7, p. 533, doi. 10.1007/s00535-007-2059-3
- By:
- Publication type:
- Article
Granular cell tumor occurring in the sigmoid colon treated by endoscopic mucosal resection using a transparent cap (EMR-C).
- Published in:
- Journal of Gastroenterology, 2003, v. 38, n. 4, p. 385, doi. 10.1007/s005350300068
- By:
- Publication type:
- Article
Evaluation of endoscopic injection sclerotherapy with and without simultaneous ligation for the treatment of esophageal varices.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1757, doi. 10.1093/jjco/hyab159
- By:
- Publication type:
- Article
Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 9, p. 1383, doi. 10.1093/jjco/hyab086
- By:
- Publication type:
- Article
Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 8, p. 859, doi. 10.1093/jjco/hyaa042
- By:
- Publication type:
- Article
A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 11, p. 1002, doi. 10.1093/jjco/hyx114
- By:
- Publication type:
- Article
A Phase 1 study evaluating AMG 337 in Asian patients with advanced solid tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 8, p. 772, doi. 10.1093/jjco/hyx067
- By:
- Publication type:
- Article
Bevacizumab safety in Japanese patients with colorectal cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 3, p. 234, doi. 10.1093/jjco/hyv182
- By:
- Publication type:
- Article
Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 1, p. 43, doi. 10.1093/jjco/hyu174
- By:
- Publication type:
- Article
Immunotherapy for Esophageal Squamous Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 5, p. 1, doi. 10.1007/s11912-017-0590-9
- By:
- Publication type:
- Article
Natural Course of Chronic Hepatitis C.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1993, v. 88, n. 2, p. 240
- By:
- Publication type:
- Article
A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.897991
- By:
- Publication type:
- Article
Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences.
- Published in:
- Journal of Human Genetics, 2007, v. 52, n. 10, p. 804, doi. 10.1007/s10038-007-0186-6
- By:
- Publication type:
- Article
Depletion of central memory CD8<sup>+</sup> T cells might impede the antitumor therapeutic effect of Mogamulizumab.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27574-0
- By:
- Publication type:
- Article
A phase 1/1b, open-label, dose-escalation study of PD-1 inhibitor, cetrelimab alone and in combination with FGFR inhibitor, erdafitinib in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 4, p. 376, doi. 10.1007/s10637-024-01433-3
- By:
- Publication type:
- Article
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 3, p. 261, doi. 10.1007/s10637-024-01422-6
- By:
- Publication type:
- Article
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 4, p. 762, doi. 10.1007/s10637-022-01247-1
- By:
- Publication type:
- Article
Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1559, doi. 10.1007/s10637-021-01107-4
- By:
- Publication type:
- Article
A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 469, doi. 10.1007/s10637-020-01001-5
- By:
- Publication type:
- Article
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 152, doi. 10.1007/s10637-020-00942-1
- By:
- Publication type:
- Article
Correction to: Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1836, doi. 10.1007/s10637-020-00968-5
- By:
- Publication type:
- Article
Phase I dose-escalation study of the safety, tolerability, and pharmacokinetics of aflibercept in combination with S-1 in Japanese patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1390, doi. 10.1007/s10637-019-00888-z
- By:
- Publication type:
- Article
Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1175, doi. 10.1007/s10637-019-00859-4
- By:
- Publication type:
- Article
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 445, doi. 10.1007/s10637-019-00780-w
- By:
- Publication type:
- Article
A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 5, p. 1061, doi. 10.1007/s10637-018-0713-7
- By:
- Publication type:
- Article
First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 507, doi. 10.1007/s10637-018-0697-3
- By:
- Publication type:
- Article
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 271, doi. 10.1007/s10637-018-0627-4
- By:
- Publication type:
- Article
Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 424, doi. 10.1007/s10637-017-0514-4
- By:
- Publication type:
- Article
A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 584, doi. 10.1007/s10637-016-0370-7
- By:
- Publication type:
- Article
Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1068, doi. 10.1007/s10637-015-0271-1
- By:
- Publication type:
- Article
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experience.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 664, doi. 10.1007/s10637-015-0231-9
- By:
- Publication type:
- Article
Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1413, doi. 10.1007/s10147-022-02200-1
- By:
- Publication type:
- Article
Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 954, doi. 10.1007/s10147-017-1130-1
- By:
- Publication type:
- Article
Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 5, p. 905, doi. 10.1007/s10147-015-0790-y
- By:
- Publication type:
- Article
Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 1, p. 38, doi. 10.1007/s10147-011-0339-7
- By:
- Publication type:
- Article
Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 1, p. 87, doi. 10.1007/s10147-011-0348-6
- By:
- Publication type:
- Article
Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC?
- Published in:
- International Journal of Clinical Oncology, 2012, v. 17, n. 6, p. 610, doi. 10.1007/s10147-011-0332-1
- By:
- Publication type:
- Article
Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors.
- Published in:
- International Journal of Clinical Oncology, 2009, v. 14, n. 4, p. 307, doi. 10.1007/s10147-008-0855-2
- By:
- Publication type:
- Article
Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene.
- Published in:
- International Journal of Clinical Oncology, 2009, v. 14, n. 2, p. 143, doi. 10.1007/s10147-008-0822-y
- By:
- Publication type:
- Article
Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2008, v. 13, n. 2, p. 144, doi. 10.1007/s10147-007-0737-z
- By:
- Publication type:
- Article
TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 2, p. 398, doi. 10.4143/crt.2017.074
- By:
- Publication type:
- Article
Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 687, doi. 10.4143/crt.2014.225
- By:
- Publication type:
- Article